OBJECTIVES: We examined relationships between herpes simplex virus type 2 (HSV-2), a biomarker for sexual risk, and HCV, a biomarker for injecting risk, with HIV among injecting drug users (IDUs) who began injecting after large-scale expansion of syringe exchange programs in New York City. METHODS: We recruited 337 heroin and cocaine users who began injecting in 1995 or later from persons entering drug detoxification. We administered a structured interview covering drug use and HIV risk behavior and collected serum samples for HIV, HCV, and HSV-2 testing. RESULTS: HIV prevalence was 8%, HSV-2 39%, and HCV 55%. We found a significant association between HSV-2 and HIV (odds ratio [OR] = 7.9; 95% confidence interval [CI] = 2.9, 21.4) and no association between HCV and HIV (OR = 1.14; 95% CI = 0.5, 2.6). Black IDUs had the highest prevalence of HSV-2 (76%) and HIV (24%) but the lowest prevalence of HCV (34%). CONCLUSIONS: Most HIV infections among these IDUs occurred through sexual transmission. The relative importance of injecting versus sexual transmission of HIV may be critical for understanding racial/ethnic disparities in HIV infection.
OBJECTIVES: We examined relationships between herpes simplex virus type 2 (HSV-2), a biomarker for sexual risk, and HCV, a biomarker for injecting risk, with HIV among injecting drug users (IDUs) who began injecting after large-scale expansion of syringe exchange programs in New York City. METHODS: We recruited 337 heroin and cocaine users who began injecting in 1995 or later from persons entering drug detoxification. We administered a structured interview covering drug use and HIV risk behavior and collected serum samples for HIV, HCV, and HSV-2 testing. RESULTS:HIV prevalence was 8%, HSV-2 39%, and HCV 55%. We found a significant association between HSV-2 and HIV (odds ratio [OR] = 7.9; 95% confidence interval [CI] = 2.9, 21.4) and no association between HCV and HIV (OR = 1.14; 95% CI = 0.5, 2.6). Black IDUs had the highest prevalence of HSV-2 (76%) and HIV (24%) but the lowest prevalence of HCV (34%). CONCLUSIONS: Most HIV infections among these IDUs occurred through sexual transmission. The relative importance of injecting versus sexual transmission of HIV may be critical for understanding racial/ethnic disparities in HIV infection.
Authors: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman Journal: Am J Public Health Date: 2005-06-28 Impact factor: 9.308
Authors: D C Des Jarlais; T Perlis; S R Friedman; S Deren; T Chapman; J L Sotheran; S Tortu; M Beardsley; D Paone; L V Torian; S T Beatrice; E DeBernardo; E Monterroso; M Marmor Journal: Am J Public Health Date: 1998-12 Impact factor: 9.308
Authors: Catharina E A Lindenburg; Anneke Krol; Colette Smit; Marcel C A Buster; Roel A Coutinho; Maria Prins Journal: AIDS Date: 2006-08-22 Impact factor: 4.177
Authors: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Holly Hagan; Sara Beatrice; Lou Smith; Judith Wethers; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman Journal: AIDS Date: 2005-10 Impact factor: 4.177
Authors: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman Journal: AIDS Date: 2007-01-11 Impact factor: 4.177
Authors: Saidi H Kapiga; Noel E Sam; Heejung Bang; Quanhong Ni; Trong T H Ao; Ireen Kiwelu; Sarah Chiduo; Uzodinma Ndibe; George Seage; Paul Coplan; John Shao; Zeda F Rosenberg; Max Essex Journal: J Infect Dis Date: 2007-03-15 Impact factor: 5.226
Authors: D C Des Jarlais; S R Friedman; J L Sotheran; J Wenston; M Marmor; S R Yancovitz; B Frank; S Beatrice; D Mildvan Journal: JAMA Date: 1994-01-12 Impact factor: 56.272
Authors: B R Edlin; K L Irwin; D D Ludwig; H V McCoy; Y Serrano; C Word; B P Bowser; S Faruque; C B McCoy; R F Schilling Journal: J Psychoactive Drugs Date: 1992 Oct-Dec
Authors: Esther E Freeman; Helen A Weiss; Judith R Glynn; Pamela L Cross; James A Whitworth; Richard J Hayes Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: D Panagiotoglou; M Olding; B Enns; D J Feaster; C Del Rio; L R Metsch; R M Granich; S A Strathdee; B D L Marshall; M R Golden; S Shoptaw; B R Schackman; B Nosyk Journal: AIDS Behav Date: 2018-09
Authors: Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David C Perlman; Holly Hagan; Emily F Dauria; Hannah L F Cooper Journal: Subst Use Misuse Date: 2014-02-06 Impact factor: 2.164
Authors: Christina S Meade; Ryan R Lion; Daniella M Cordero; Melissa H Watt; John A Joska; Hetta Gouse; Warren Burnhams Journal: AIDS Behav Date: 2016-10
Authors: Kathryn M Nowotny; Jessica Frankeberger; Victoria E Rodriguez; Avelardo Valdez; Alice Cepeda Journal: Behav Med Date: 2018-05-09 Impact factor: 3.104
Authors: Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David Perlman; Holly Hagan; Hannah L F Cooper Journal: J Urban Health Date: 2014-06 Impact factor: 3.671